Delfino, Jea .

HRN: 27-06-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
CEFUROXIME 500MG (TAB)
08/01/2025
08/08/2025
PO
500mg
BID
S/P NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines